Hematology & Oncology

Division of Hematology and Oncology

Randy A. Brown, MD Randy A. Brown, MD
Clinical Professor
Clinical Director for the Blood and Marrow Transplant Program

1600 SW Archer Road/Box 100278
Gainesville, FL  32610-0278
(352) 273-7832/ FAX (352) 273-5006
Email:  Randy.Brown@medicine.ufl.edu

Dr Brown is Clinical Professor of Medicine in the Blood and Marrow Transplant Program.  His areas of special interest include treatment of acute leukemia and myelodysplasia focusing both on novel therapies as well as stem cell transplantation.  Dr Brown is also interested in stem cell mobilization and was involved in the initial trial of allogeneic stem cell transplantation at Washington University.  He is board certified in Internal Medicine, Hematology and Oncology. 

Training:

Degree
Program		 Institution Field/Specialty
BS Stanford University Biology
MD Case Western Reserve University Medicine
Fellowship Washington University School of Medicine Hematology/Oncology

Representative Publications:

  • Devine SM, Brown RA, Mathews V, Trinkaus K, Khoury H, Adkins D, Vij R, Sempek D, Graubert T, Tomasson M, Goodnough LT, DiPersio JF.  Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.  Bone Marrow Transplant. 2005 Sep;36(6):531-
  • Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, Dipersio J, Adkins D.  Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.  Biol Blood Marrow Transplant. 2004 May;10(5):310-9.
  • Westervelt P, Brown RA, Adkins DR, Khoury H, Curtin P, Hurd D, Luger SM, Ma MK, Ley TJ, DiPersio JF.  Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide.
    Blood. 2001 Jul 15;98(2):266-71
  • Shpall E, Wheeler C, Turner S, Yanovich S, Brown R, Pecora A, Shea T, Mangan K, Williams S, LeMaistre, F, Long G, Jones R, Davis M, Murphy‑Filkins R, Parker W, Glaspy J: A Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High‑Risk Breast Cancer Patients. Blood B.‑2491‑2501,1999.
  • Brown RA, Adkins D, Khoury H, Vij R, Goodnough LT, Shenoy S, DiPersio JF: Long term follow‑up of high‑risk allogeneic peripheral blood stem cell transplant recipients: graft‑versus‑host disease and transplant‑related mortality. Journal of Clinical Oncology 17.806‑81 Z 1999.

Primary Navigation